1.Transabdominal bowel ultrasound for monitoring efficacy of vedolizumab treatment in patients with moderate-to-severe ulcerative colitis
Lihua YAN ; Xiaodong LUO ; Shuochun CHEN ; Xinying YU ; Ziyi QIU ; Yixin CHEN ; Caihe CHEN ; Buzhi SONG ; Yingjia LI
Chinese Journal of Medical Imaging Technology 2025;41(10):1687-1690
Objective To observe the value of transabdominal bowel ultrasound for monitoring therapeutic efficacy of vedolizumab in patients with moderate-to-severe ulcerative colitis.Methods Totally 47 ulcerative colitis patients with Mayo endoscopic score(MES)≥2 and treated with vedolizumab were retrospectively included.Transabdominal bowel ultrasound examinations were performed at baseline,at the end of induction therapy,also 3 and 6 months after maintenance therapy,while colonoscopy was performed at baseline and 6 months after maintenance therapy.According to colonoscopy results 6 months after maintenance therapy,the patients were divided into improved group(MES≤1 or MES reduction≥1,n=25)and non-improved group(n=22),and ultrasonic findings of sigmoid colon were compared between and within groups.Results At baseline,no significant difference of ultrasonic findings of sigmoid colon was observed between groups(all P>0.05),whereas differences of bowel wall thickness at the end of induction therapy,of Limberg grade and abnormal perienteric lymph nodes 3 months after maintenance therapy,as well as bowel wall stratification 6 months after maintenance therapy were noticed between groups(all P<0.05).Within improved group,compared with those in baseline,bowel wall thickness improved at all time points after the beginning of treatment,Limberg grade improved 3 and 6 months after maintenance therapy,while bowel wall stratification,abnormal perienteric lymph node and perienteric fat edema improved 6 months after maintenance therapy(all P<0.05).Meanwhile,no significant change of ultrasonic findings of sigmoid colon was observed in non-improved group during the above periods(all P>0.05).Conclusion Transabdominal bowel ultrasound could be used to accurately monitor the therapeutic efficacy of vedolizumab in patients with moderate-to-severe ulcerative colitis.
2.Enzymatic MBH reaction catalyzed by an artificial enzyme designed with the introduction of an unnatural tertiary amine cofactor.
Ya WEI ; Chongwen CHEN ; Yingjia TONG ; Zhi ZHOU
Chinese Journal of Biotechnology 2025;41(1):376-384
As the chip of synthetic biology, enzymes play a vital role in the bio-manufacturing industry. The development of diverse functional enzymes can provide a rich toolbox for the development of synthetic biology. This article reports the construction of an artificial enzyme with the introduction of a non-natural cofactor. By introducing the 4-dimethylaminopyridine (DMAP) cofactor into the optimal protein skeleton via covalent bonds based on a click-chemistry strategy, we successfully constructed a novel artificial enzyme with the DMAP cofactor as the catalytic center. The artificial enzyme successfully catalyzed an unnatural asymmetric Morita-Baylis- Hillman (MBH) reaction between cycloketenone and p-nitrobenzaldehyde, with a conversion rate of 90% and enantioselectivity (e.e.) of 38%. This study not only provides an effective strategy for the design of new artificial enzymes but also establishes a theoretical basis for the development of unnatural biocatalytic MBH reactions.
Biocatalysis
;
4-Aminopyridine/chemistry*
;
Enzymes/metabolism*
;
Coenzymes/chemistry*
;
Benzaldehydes/chemistry*
;
Protein Engineering/methods*
;
Click Chemistry
3.Application and validation of a tumor-deposit-based modified pN staging(mpN)system for prognostic prediction in gastric cancer
Bowen HUANG ; Junzhi ZHOU ; Zhihao CHEN ; Yingjia CHEN ; Ruopeng ZHANG ; Wenkai WANG ; Junjiang WANG ; Baiwei ZHAO
Chinese Journal of General Surgery 2025;34(10):2095-2105
Background and Aims:Tumor deposits(TDs)may influence prognosis beyond the current 8th edition AJCC pTNM nodal classification in gastric cancer(GC).This study investigates the prognostic value of TD number and proposes an improved pN staging(mpN)that classifies patients with TD number>1 as pN3b.We validated the mpN staging against the 8th AJCC pN staging.Methods:A dual-center retrospective cohort study was performed,including 1 327 patients who underwent radical gastrectomy at Sun Yat-sen University Cancer Center(2011-2015;test cohort)and 340 patients from Guangdong Provincial People's Hospital(2015-2022;validation cohort).Patients were dichotomized into low-TD(≤1)and high-TD(>1)groups.Outcomes were overall survival(OS)and disease-free survival(DFS).Survival analyses used Kaplan-Meier curves,IPTW,and Cox regression.Predictive performance of staging systems was assessed by time-dependent ROC(tROC)/tAUC,concordance index(C-index)and Akaike information criterion(AIC).Results:TDs were present in 435/1 327(32.7%)in the test cohort.Presence of TD was associated with worse OS(IPTW-adjusted HR=2.69,95%CI=2.18-3.31,P<0.01)and DFS(HR=2.82,95%CI=2.32-3.42,P<0.01).In multivariable models,TD remained an independent adverse factor for OS(HR=1.65,95%CI=1.34-2.05;P<0.01)and DFS(HR=1.74,95%CI=1.43-2.11,P<0.01).Increasing TD number correlated with progressively poorer survival;X-tile identified>1 as an optimal cutoff,with high-TD patients showing markedly worse outcomes(OS:adjusted HR=3.65,95%CI=2.74-4.88;DFS:adjusted HR=3.74,95%CI=2.85-4.91;both P<0.01).Incorporation of TD number into the mpN staging(assigning TD>1 to pN3b)improved prognostic discrimination:in the test cohort 5-year OS tAUC was 0.746 for mpN vs.0.703 for AJCC pN(C-index 0.738 vs.0.721,AIC 5 805.27 vs.5 849.30);similar improvements were observed in the validation cohort.Conclusion:TD presence and number exert significant negative prognostic impact in GC.Classifying patients with TD number>1 as pN3b enhances prognostic accuracy.Routine reporting of TD counts and further prospective multicenter validation of mpN staging are warranted.
4.Application and validation of a tumor-deposit-based modified pN staging(mpN)system for prognostic prediction in gastric cancer
Bowen HUANG ; Junzhi ZHOU ; Zhihao CHEN ; Yingjia CHEN ; Ruopeng ZHANG ; Wenkai WANG ; Junjiang WANG ; Baiwei ZHAO
Chinese Journal of General Surgery 2025;34(10):2095-2105
Background and Aims:Tumor deposits(TDs)may influence prognosis beyond the current 8th edition AJCC pTNM nodal classification in gastric cancer(GC).This study investigates the prognostic value of TD number and proposes an improved pN staging(mpN)that classifies patients with TD number>1 as pN3b.We validated the mpN staging against the 8th AJCC pN staging.Methods:A dual-center retrospective cohort study was performed,including 1 327 patients who underwent radical gastrectomy at Sun Yat-sen University Cancer Center(2011-2015;test cohort)and 340 patients from Guangdong Provincial People's Hospital(2015-2022;validation cohort).Patients were dichotomized into low-TD(≤1)and high-TD(>1)groups.Outcomes were overall survival(OS)and disease-free survival(DFS).Survival analyses used Kaplan-Meier curves,IPTW,and Cox regression.Predictive performance of staging systems was assessed by time-dependent ROC(tROC)/tAUC,concordance index(C-index)and Akaike information criterion(AIC).Results:TDs were present in 435/1 327(32.7%)in the test cohort.Presence of TD was associated with worse OS(IPTW-adjusted HR=2.69,95%CI=2.18-3.31,P<0.01)and DFS(HR=2.82,95%CI=2.32-3.42,P<0.01).In multivariable models,TD remained an independent adverse factor for OS(HR=1.65,95%CI=1.34-2.05;P<0.01)and DFS(HR=1.74,95%CI=1.43-2.11,P<0.01).Increasing TD number correlated with progressively poorer survival;X-tile identified>1 as an optimal cutoff,with high-TD patients showing markedly worse outcomes(OS:adjusted HR=3.65,95%CI=2.74-4.88;DFS:adjusted HR=3.74,95%CI=2.85-4.91;both P<0.01).Incorporation of TD number into the mpN staging(assigning TD>1 to pN3b)improved prognostic discrimination:in the test cohort 5-year OS tAUC was 0.746 for mpN vs.0.703 for AJCC pN(C-index 0.738 vs.0.721,AIC 5 805.27 vs.5 849.30);similar improvements were observed in the validation cohort.Conclusion:TD presence and number exert significant negative prognostic impact in GC.Classifying patients with TD number>1 as pN3b enhances prognostic accuracy.Routine reporting of TD counts and further prospective multicenter validation of mpN staging are warranted.
5.Transabdominal bowel ultrasound for monitoring efficacy of vedolizumab treatment in patients with moderate-to-severe ulcerative colitis
Lihua YAN ; Xiaodong LUO ; Shuochun CHEN ; Xinying YU ; Ziyi QIU ; Yixin CHEN ; Caihe CHEN ; Buzhi SONG ; Yingjia LI
Chinese Journal of Medical Imaging Technology 2025;41(10):1687-1690
Objective To observe the value of transabdominal bowel ultrasound for monitoring therapeutic efficacy of vedolizumab in patients with moderate-to-severe ulcerative colitis.Methods Totally 47 ulcerative colitis patients with Mayo endoscopic score(MES)≥2 and treated with vedolizumab were retrospectively included.Transabdominal bowel ultrasound examinations were performed at baseline,at the end of induction therapy,also 3 and 6 months after maintenance therapy,while colonoscopy was performed at baseline and 6 months after maintenance therapy.According to colonoscopy results 6 months after maintenance therapy,the patients were divided into improved group(MES≤1 or MES reduction≥1,n=25)and non-improved group(n=22),and ultrasonic findings of sigmoid colon were compared between and within groups.Results At baseline,no significant difference of ultrasonic findings of sigmoid colon was observed between groups(all P>0.05),whereas differences of bowel wall thickness at the end of induction therapy,of Limberg grade and abnormal perienteric lymph nodes 3 months after maintenance therapy,as well as bowel wall stratification 6 months after maintenance therapy were noticed between groups(all P<0.05).Within improved group,compared with those in baseline,bowel wall thickness improved at all time points after the beginning of treatment,Limberg grade improved 3 and 6 months after maintenance therapy,while bowel wall stratification,abnormal perienteric lymph node and perienteric fat edema improved 6 months after maintenance therapy(all P<0.05).Meanwhile,no significant change of ultrasonic findings of sigmoid colon was observed in non-improved group during the above periods(all P>0.05).Conclusion Transabdominal bowel ultrasound could be used to accurately monitor the therapeutic efficacy of vedolizumab in patients with moderate-to-severe ulcerative colitis.
6.Combined ultrasound and clinical characteristics to predict the treatment time of 90Sr radioisotope applicator therapy for pathologic scars
Yanjing CHEN ; Yongshuai QI ; Zhouyue JIANG ; Yanyan ZHANG ; Ting LANG ; Yue LIN ; Min CHANG ; Yingjia LI
Chinese Journal of Ultrasonography 2024;33(7):603-608
Objective:To combine ultrasound and clinical characteristics for predicting the treatment time of strontium 90( 90Sr) radioisotope applicator therapy for pathological scars when the therapeutic effect meets the clinical effective criteria. Methods:From September 2022 to October 2023, 48 patients (90 lesions) with pathological scars who underwent 90Sr radioisotope applicator therapy at the Department of Nuclear Medicine, Nanfang Hospital, Southern Medical University were prospectively collected. The clinically effective criteria of 90Sr radioisotope applicator therapy for pathological scars were defined as a reduction of the superficial height of the scar higher than 50%. All lesions were divided into short period treatment group (2 months, 38 lesions) and long period treatment group (>2 months, 52 lesions) according to the duration of treatment when the therapeutic effect met the clinical criteria. Univariate comparative analyses of ultrasound and clinical characteristics between the two groups were performed. The statistically significant variates were used to build a multivariate logistic regression model for analyzing the independent predictors of the treatment time of 90Sr radioisotope applicator therapy for pathological scars. Results:Family history, blood flow signal, disease duration, age, and scar Young′s modulus were independent predictors of the effective treatment time of 90Sr radioisotope applicator therapy for pathological scars (all P<0.05). By using the selected variables, a predictive model was developed, area under the ROC curve (AUC) were 0.886 (95% CI=0.817-0.955, P<0.001), and the calibration curve showed that the model was well calibrated(χ 2=5.668, P=0.684). Conclusions:The multivariate logistic regression model with family history, blood flow signal, disease duration, age, and scar Young′s modulus could be used to predict the treatment time of 90Sr radioisotope applicator therapy for pathologic scars, which can help to guide the design of treatment plan, reduce unnecessary radiation damage, and improve patient compliance.
7.Value of transabdominal intestinal ultrasound in monitoring the efficacy of anti-tumor necrosis factor-α therapy for Crohn′s disease with intestinal fistula
Lihua YAN ; Xiaodong LUO ; Shuochun CHEN ; Yingjia LI
Chinese Journal of Ultrasonography 2024;33(12):1050-1055
Objective:To observe the application value of transabdominal intestinal ultrasound in monitoring the efficacy of anti-tumor necrosis factor-α (TNF-α) therapy in Crohn′s disease patients with enteric fistulas.Methods:A retrospective analysis was performed on 54 patients with Crohn′s disease complicated by enteric fistulas, who were treated with anti-TNF-α therapy at Nanfang Hospital, Southern Medical University from April 2020 to April 2024. Based on treatment outcomes, the patients were categorized into responder group and non-responder group.Intestinal ultrasound parameters were collected at baseline, at the end of induction therapy, and at 3 and 6 months of maintenance therapy. The changes in intestinal ultrasound parameters during anti-TNF-α treatment were analyzed and compared between the responder and non-responder groups at these time points.Results:After a 6-month follow-up, among the 54 patients, 39 patients were classified as clinical responders and 15 as clinical non-responders, resulting in a disease control rate of 72.22% (39/54) for anti-TNF-α therapy. In the responder group, significant improvements were observed in bowel wall thickness, layering, and the length of perienteric cellulitis or abscesses at the end of induction therapy, and at 3 and 6 months of maintenance therapy compared to baseline (all P<0.05). Additionally, the Limberg grading of bowel wall blood supply also showed significant improvement at 3 and 6 months of maintenance therapy compared to baseline (all P<0.05). Perienteric fat tissue edema showed significant improvement at 6 months of maintenance therapy compared to baseline ( P<0.05). Moreover, 28.21% (11/39) patients in the responder group achieved fistula healing after 6 months of maintenance therapy. In the non-responder group, there were no statistically significant differences in the aforementioned ultrasound parameters at any time point during the observation period (all P>0.05). Conclusions:Intestinal ultrasound can accurately reflect the changes in disease status in Crohn′s disease patients with enteric fistulas undergoing anti-TNF-α therapy, and it may be a reliable method for monitoring drug efficacy.
8.Value of transabdominal intestinal ultrasound in monitoring the efficacy of anti-tumor necrosis factor-α therapy for Crohn′s disease with intestinal fistula
Lihua YAN ; Xiaodong LUO ; Shuochun CHEN ; Yingjia LI
Chinese Journal of Ultrasonography 2024;33(12):1050-1055
Objective:To observe the application value of transabdominal intestinal ultrasound in monitoring the efficacy of anti-tumor necrosis factor-α (TNF-α) therapy in Crohn′s disease patients with enteric fistulas.Methods:A retrospective analysis was performed on 54 patients with Crohn′s disease complicated by enteric fistulas, who were treated with anti-TNF-α therapy at Nanfang Hospital, Southern Medical University from April 2020 to April 2024. Based on treatment outcomes, the patients were categorized into responder group and non-responder group.Intestinal ultrasound parameters were collected at baseline, at the end of induction therapy, and at 3 and 6 months of maintenance therapy. The changes in intestinal ultrasound parameters during anti-TNF-α treatment were analyzed and compared between the responder and non-responder groups at these time points.Results:After a 6-month follow-up, among the 54 patients, 39 patients were classified as clinical responders and 15 as clinical non-responders, resulting in a disease control rate of 72.22% (39/54) for anti-TNF-α therapy. In the responder group, significant improvements were observed in bowel wall thickness, layering, and the length of perienteric cellulitis or abscesses at the end of induction therapy, and at 3 and 6 months of maintenance therapy compared to baseline (all P<0.05). Additionally, the Limberg grading of bowel wall blood supply also showed significant improvement at 3 and 6 months of maintenance therapy compared to baseline (all P<0.05). Perienteric fat tissue edema showed significant improvement at 6 months of maintenance therapy compared to baseline ( P<0.05). Moreover, 28.21% (11/39) patients in the responder group achieved fistula healing after 6 months of maintenance therapy. In the non-responder group, there were no statistically significant differences in the aforementioned ultrasound parameters at any time point during the observation period (all P>0.05). Conclusions:Intestinal ultrasound can accurately reflect the changes in disease status in Crohn′s disease patients with enteric fistulas undergoing anti-TNF-α therapy, and it may be a reliable method for monitoring drug efficacy.
9.A content analysis of the provincial laws and regulations for voluntary blood donation
Huiying HU ; Li CHEN ; Zijia ZHANG ; Ying CHANG ; Guiqi ZHAO ; Lifen LU ; Yan ZHANG ; Qingming WANG ; Yingjia JIANG ; Hai QI ; Ming ZHU
Chinese Journal of Blood Transfusion 2022;35(8):873-877
【Objective】 To perform quantitative analysis on the sample provincial laws and regulations for voluntary blood donation, and provide reference for further revision of laws and regulations. 【Methods】 31 study samples were current provincial laws and regulations for voluntary blood donation that can be collected from open sources. The issue date and the revision date of each sample were recorded. With "The Blood Donation Law of the People’s Republic of China" as reference, 5 categories were formed and additional clauses in samples were coded and rated following content analysis procedures. Sample provinces were divided into two groups based on donation rate and their differences in evaluation scores of categories were examined using rank sum test. 【Results】 Until December, 2021, 31 sample provinces had issued and implemented provincial laws and regulation for voluntary blood donation, and 14 of which had been revised. Many detailed clauses (total score 9.32±3.09) were added in sample provincial laws and regulations, more clauses were added in the categories of 'related government agencies and their responsibilities’, 'management of clinical blood use’ and 'rewards and punishment’. Sample provinces were divided into two groups according to the donation rate per 1 000 people recommended by World Health Organization(10‰). Compared to lower donation rate group, the total score and sub score in the categories of 'basic principles’, 'management of blood collection and supply’ were significantly higher in higher donation rate group. 【Conclusion】 In revision and improvement of provincial laws and regulations, 'basic principles’ and 'management of blood collection and supply’ could be considered. This assay mainly tries to provide a new research perspective and perform quantitative analysis on content of sample provincial laws and regulation for voluntary blood donation, the actual effect of the results in this study need longer time to be examined, and we will keep following its new advances.
10.Uphold the original intention and practice the mission: 2022 Fudan university public health doctorate academic forum
Minyang CHEN ; Bo ZHENG ; Shiyi BAO ; Haifeng MA ; Jiaojiao SHI ; Luwan LAN ; Shaojie LIU ; Yingjia YU
Shanghai Journal of Preventive Medicine 2022;34(12):1267-1270
The 2022 Fudan university doctorate academic public health forum hosted by the graduate school of Fudan university, the graduate work department of the party committee of Fudan university, and the school of public health of Fudan university was successfully held on December 10, 2022 in the school of public health of Fudan university. In the early stage, a total of 53 manuscripts from nationwide universities and research institutes were received, and 10 were selected as excellent papers to participate in the forum report. More than 100 teachers and students attended the forum. Focusing on the theme of " Adhering to the original ambition of scientific research to serve the country and practicing the mission of public health youth", the major contents of the forums included excellent paper reports in the morning and round-table discussion in the afternoon. Experts and students conducted discussions and communications on prevention, control and management of public health emergencies. It is of great benefit for students to uphold the original intention,practice the mission and further improve public health research.

Result Analysis
Print
Save
E-mail